Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis
Open Access
- 6 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 20 (1), 1-14
- https://doi.org/10.1186/s12885-020-06901-6
Abstract
Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer death worldwide and in China. We know miRNAs influence gene expression in tumorigenesis, but it is unclear how miRNAs affect gene expression or influence survival at the genome-wide level in ESCC. We performed miRNA and mRNA expression arrays in 113 ESCC cases with tumor/normal matched tissues to identify dysregulated miRNAs, to correlate miRNA and mRNA expressions, and to relate miRNA and mRNA expression changes to survival and clinical characteristics. Thirty-nine miRNAs were identified whose tumor/normal tissue expression ratios showed dysregulation (28 down- and 11 up-regulated by at least two-fold with P < 1.92E-04), including several not previously reported in ESCC (miR-885-5p, miR-140-3p, miR-708, miR-639, miR-596). Expressions of 16 miRNAs were highly correlated with expressions of 195 genes (P < 8.42E-09; absolute rho values 0.51–0.64). Increased expressions of miRNA in tumor tissue for both miR-30e* and miR-124 were associated with increased survival (P < 0.05). Similarly, nine probes in eight of 818 dysregulated genes had RNA expression levels that were nominally associated with survival, including NF1, ASXL1, HSPA4, TGOLN2, BAIAP2, EZH2, CHAF1A, SUPT7L. Our characterization and integrated analysis of genome-wide miRNA and gene expression in ESCC provides insights into the expression of miRNAs and their relation to regulation of RNA targets in ESCC tumorigenesis, and suggest opportunities for the future development of miRs and mRNAs as biomarkers for early detection, diagnosis, and prognosis in ESCC.Keywords
Funding Information
- Division of Cancer Epidemiology and Genetics, National Cancer Institute
This publication has 29 references indexed in Scilit:
- Clinical impact of serum exosomal microRNA‐21 as a clinical biomarker in human esophageal squamous cell carcinomaCancer, 2012
- miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemiaNature Communications, 2012
- Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinomaBritish Journal of Cancer, 2011
- MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cellsJournal of Translational Medicine, 2011
- MicroRNAs in Cancer: Small Molecules With a Huge ImpactJournal of Clinical Oncology, 2009
- Causes and consequences of microRNA dysregulation in cancerNature Reviews Genetics, 2009
- MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with SurvivalClinical Cancer Research, 2009
- MicroRNA-21 Regulates the Proliferation and Invasion in Esophageal Squamous Cell CarcinomaClinical Cancer Research, 2009
- Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in CancerScience, 2008
- MicroRNA expression profiles of esophageal cancerThe Journal of Thoracic and Cardiovascular Surgery, 2008